IL150390A0 - Pharmaceutical compositions containing diacerein for treating psoriasis - Google Patents

Pharmaceutical compositions containing diacerein for treating psoriasis

Info

Publication number
IL150390A0
IL150390A0 IL15039001A IL15039001A IL150390A0 IL 150390 A0 IL150390 A0 IL 150390A0 IL 15039001 A IL15039001 A IL 15039001A IL 15039001 A IL15039001 A IL 15039001A IL 150390 A0 IL150390 A0 IL 150390A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
treating psoriasis
containing diacerein
diacerein
Prior art date
Application number
IL15039001A
Other languages
English (en)
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of IL150390A0 publication Critical patent/IL150390A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15039001A 2000-01-12 2001-01-08 Pharmaceutical compositions containing diacerein for treating psoriasis IL150390A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (1)

Publication Number Publication Date
IL150390A0 true IL150390A0 (en) 2002-12-01

Family

ID=4291590

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15039001A IL150390A0 (en) 2000-01-12 2001-01-08 Pharmaceutical compositions containing diacerein for treating psoriasis
IL150390A IL150390A (en) 2000-01-12 2002-06-25 Pharmaceutical compositions containing diacerein for treating psoriasis

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150390A IL150390A (en) 2000-01-12 2002-06-25 Pharmaceutical compositions containing diacerein for treating psoriasis

Country Status (22)

Country Link
US (2) US6844365B2 (cs)
EP (1) EP1248608B1 (cs)
JP (1) JP4912554B2 (cs)
CN (1) CN1187045C (cs)
AR (1) AR026801A1 (cs)
AT (1) ATE254913T1 (cs)
AU (1) AU776324B2 (cs)
BR (2) BR0107493A (cs)
CA (1) CA2396111C (cs)
CZ (1) CZ301129B6 (cs)
DE (1) DE60101309T2 (cs)
DK (1) DK1248608T3 (cs)
ES (1) ES2210120T3 (cs)
IL (2) IL150390A0 (cs)
MX (1) MXPA02006610A (cs)
PL (1) PL212010B1 (cs)
PT (1) PT1248608E (cs)
RU (1) RU2266740C2 (cs)
SK (1) SK286589B6 (cs)
TR (1) TR200400228T4 (cs)
WO (1) WO2001051044A2 (cs)
ZA (1) ZA200205148B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
CN102961746B (zh) 2005-05-16 2016-06-15 艾伯维生物技术有限公司 TNFα抑制剂治疗腐蚀性多关节炎的用途
EP2666472A3 (en) * 2006-04-10 2014-04-02 Abbott Biotechnology Ltd Uses and compositions for treatment of psoriatic arthritis
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药(中山)有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
JP6085552B2 (ja) * 2010-04-08 2017-02-22 ティダブリューアイ・バイオテクノロジー・インコーポレイテッドTWI Biotechnology, Inc. 糖尿病の補助療法としてのディアセレインの使用方法
US20180311199A1 (en) * 2016-01-12 2018-11-01 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
SG11201907443PA (en) * 2017-01-19 2019-09-27 Twi Biotechnology Inc Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
AU2019245521B2 (en) * 2018-03-29 2024-10-31 S.I.S Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
IL150390A (en) 2007-07-24
ZA200205148B (en) 2003-06-26
SK9912002A3 (en) 2003-02-04
WO2001051044A3 (en) 2002-03-28
AU2213201A (en) 2001-07-24
PL212010B1 (pl) 2012-07-31
CA2396111C (en) 2008-12-02
CZ20022382A3 (cs) 2002-11-13
PL356784A1 (pl) 2004-07-12
CA2396111A1 (en) 2001-07-19
US6844365B2 (en) 2005-01-18
MXPA02006610A (es) 2004-09-10
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
EP1248608A2 (en) 2002-10-16
WO2001051044A2 (en) 2001-07-19
AU776324B2 (en) 2004-09-02
US20020143057A1 (en) 2002-10-03
CN1187045C (zh) 2005-02-02
CN1395484A (zh) 2003-02-05
TR200400228T4 (tr) 2004-02-23
DE60101309D1 (de) 2004-01-08
US20050004045A1 (en) 2005-01-06
CZ301129B6 (cs) 2009-11-11
EP1248608B1 (en) 2003-11-26
ATE254913T1 (de) 2003-12-15
PT1248608E (pt) 2004-04-30
DE60101309T2 (de) 2004-09-16
AR026801A1 (es) 2003-02-26
BR0107493A (pt) 2002-10-08
BRPI0107493B8 (pt) 2021-05-25
BRPI0107493B1 (pt) 2019-04-16
ES2210120T3 (es) 2004-07-01
JP2003519653A (ja) 2003-06-24
JP4912554B2 (ja) 2012-04-11
DK1248608T3 (da) 2004-04-05

Similar Documents

Publication Publication Date Title
IL150390A0 (en) Pharmaceutical compositions containing diacerein for treating psoriasis
HUP0103160A3 (en) Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitor
IL162581A0 (en) Pharmaceutical compositions containing corticosteroids
EG24357A (en) New Pharmaceutical composition
GB2358582B (en) Pharmaceutical compositions
HUP0202248A3 (en) Compounds useful as anti-inflammatory agents
IL151132A0 (en) Pteridine compounds for the treatment of psoriasis
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
IL137363A (en) Pharmaceutical compositions containing mupirocin
HUP0201333A2 (en) Medicinal compositions containing anti-fas antibody
AU8576801A (en) Pharmaceutical compositions
AU1390002A (en) Pharmaceutical compositions
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
GB0008485D0 (en) Pharmaceutical compositions
EG24462A (en) Compounds for treating fundic disaccomodation
HUP0401042A3 (en) Pharmaceutical compositions suitable for treating primary insomnia
GB0009613D0 (en) Pharmaceutical compositions
IL152471A0 (en) Propofol for treatment of sepsis
EP1404303A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS BASED ON PRAVASTATIN
IL158172A0 (en) Pharmaceutical compositions containing (-)-hydroxycitric acid
GB0115588D0 (en) Novel compounds for use as photoinitiators
HUP0202791A3 (en) Pharmaceutical compositions for treating psoriasis
IL154202A0 (en) Pharmaceutical compositions for treating anorectal disorders
IL144285A0 (en) Pharmaceutical compositions containing a vasopeptidase inhibitor

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed